Vijaya Diagnostic Centre Ltd Q1 FY27 Results Analysis: PAT Surges 38%, EBITDA Margin Above Guidance

Vijaya Diagnostic Centre Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 230.98 Cr (+22.83% YoY) and PAT growth of +37.61% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

VIJAYA delivered a strong Q1 with revenue growing 22.83% YoY and EBITDA margin of 42.66%, comfortably above the ~40% guidance floor. PAT surged 37.61% YoY on operating leverage as expenses improved 301 bps as a percentage of revenue. Network expansion drove asset growth, though finance costs and leverage increased as expected during the investment phase.

Key Investment Insights

Key Positives

• Revenue grew 22.83% YoY to Rs.230.98 Cr, with sequential growth of 5.29% despite seasonal Q1 weakness
• EBITDA margin of 42.66% came in above the ~40% management guidance floor, expanding 356 bps YoY
• PAT grew 37.61% YoY to Rs.53.10 Cr, outpacing revenue growth due to operating leverage
• Total expenses as % of revenue improved from 75.99% to 72.98% YoY, a 301 bps reduction
• Net worth increased 5.7% QoQ to Rs.1,012.03 Cr from retained profits

Risk Factors

• Finance costs grew 47% YoY (Rs.11.00 Cr vs Rs.7.49 Cr) and 18% QoQ, driven by lease liabilities and working capital borrowings
• Debt-to-equity ratio increased from 57.45% to 65.70% QoQ as liabilities grew faster than assets
• Subsidiaries (new hubs) contributed Rs.12.44 Cr in revenue but a marginal PAT loss of Rs.0.05 Cr